Neuroone Medical Technologies NMTC
NASDAQ NMTC
$2.24 +0.06 (+2.63%)
At close: Aug 20, 2026 · 2:07 PM UTC

Neuroone Medical Technologies (NMTC) Invested Capital (2016 - 2024)

Neuroone Medical Technologies' (NMTC) quarterly Invested Capital came in at $121896.0 in Q1 2024, down 5.59% on a QoQ basis from $129116.0 in Q3 2023.

Neuroone Medical Technologies (NMTC) Invested Capital (2016 - 2024) Analysis & Trends

Neuroone Medical Technologies (NMTC) has 6 years of Invested Capital data on file, last reported at $121896.0 in Q1 2024.

  • Quarterly Invested Capital changed N/A year-over-year to $121896.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $121896.0 (down 5.59% YoY) and the FY2023 annual result came in at $129116.0, changed N/A from the prior year.
  • Invested Capital fell to $121896.0 in Q1 2024, from $129116.0 in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $129116.0 in Q3 2023 to a low of $121896.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Abbott Laboratories 199.44 Bn 193.84 Bn 7.27 Bn 3.01 Bn
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn 750.00 Mn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn 1.79 Bn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn 1.71 Bn
5 Edwards Lifesciences 51.90 Bn 47.65 Bn 1.35 Bn -
6 Dexcom 34.30 Bn 32.36 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn 2.00 Mn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 1.34 Bn
9 Steris 23.05 Bn 22.56 Bn 684.20 Mn 243.40 Mn
10 Neuroone Medical Technologies 19.38 Mn 17.33 Mn 1.18 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 121,896.00
Sep 30, 2023 129,116.00
Mar 31, 2019 229,000.00
Dec 31, 2018 528,000.00
Sep 30, 2018 283,000.00
Jun 30, 2018 283,000.00
Mar 31, 2018 369,124.00
Dec 31, 2017 253,000.00
Sep 30, 2017 204,074.00
Dec 31, 2016 50,000.00